PAXMAN AB (PXMBF)
Clinical trial NCT05095051 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-09-01 → 2023-07-05 3. primary completion date: 2023-09-01 → 2023-07-05 4. enrollment: 33 → 15 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical